Original Article

Metaplastic Breast Carcinoma: Analysis of Clinical and Pathologic Characteristics - A Case Series
  • Semra Salimoğlu
  • İsmail Sert
  • Mustafa Emiroğlu
  • Cem Karaali
  • Dilek Kuzukıran
  • Yasemin Akyüz Kırmızı
  • Gülden Diniz
  • Cengiz Aydın
Eur J Breast Health 2016; 12: 63-66 DOI: 10.5152/tjbh.2016.2837
Autoimmune Thyroid Disease and Breast Cancer Prognosis
  • Tolga Özmen
  • Bahadır Mahmut Güllüoğlu
  • Cumhur Şevket Yegen
  • Atilla Soran
Eur J Breast Health 2015; 11: 67-71 DOI: 10.5152/tjbh.2015.2462
Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer
  • Gamze Uğurluer
  • Sinan Yavuz
  • Züleyha Çalıkuşu
  • Ertuğrul Seyrek
  • Mustafa Kibar
  • Meltem Serin
  • Canan Ersöz
  • Orhan Demircan
Eur J Breast Health 2016; 12: 112-118 DOI: 10.5152/tjbh.2016.3031
The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
  • Yeşim Eralp
  • Leyla Kılıç
  • Gül Alço
  • Gül Başaran
  • Mutlu Doğan
  • Dilek Dinçol
  • Senem Demirci
  • Fikri İçli
  • Handan Onur
  • Pınar Saip
  • Ayfer Haydaroğlu
Eur J Breast Health 2014; 10: 209-215 DOI: 10.5152/tjbh.2014.1904
The Significance of Extent of Extracapsular Extension in Patients with T1-2 and N1 Breast Cancer
  • Gül Kanyılmaz
  • Sıddıka Fındık
  • Berrin Benli Yavuz
  • Meryem Aktan
Eur J Breast Health 2018; 14: 218-224 DOI: 10.5152/ejbh.2018.4038
Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients
  • Atilla Soran
  • Tolga Ozmen
  • Arsalan Salamat
  • Gürsel Soybir
  • Ronald Johnson
Eur J Breast Health 2019; 15: 249-255 DOI: 10.5152/ejbh.2019.4848
Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer
  • Özgecan Dülgar
  • Şennur İlvan
  • Zeynep Hande Turna
Eur J Breast Health 2020; 16: 276-281 DOI: 10.5152/ejbh.2020.5305
Effects of Primary Tumor Resection on Metastatic Breast Cancer Survival and the Predictive Power of Neutrophil: Lymphocyte Ratio on Prognosis
  • Yaşar Çöpelci
  • Umut Rıza Gündüz
  • Bülent Dinç
  • Nurhan Haluk Belen
  • Şeyda Gündüz
Eur J Breast Health 2021; 17: 322-327 DOI: 10.4274/ejbh.galenos.2021.2021-3-2 PMID:34651110
Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients
  • İzzet Doğan
  • Esra Aydın
  • Hülya Yazıcı
  • Pınar Saip
Eur J Breast Health 2022; 18: 323-328 DOI: 10.4274/ejbh.galenos.2022.2022-5-2 PMID:36248747
Tissue Expression of Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in Breast Cancers
  • Gülden Diniz
  • Ayşe Gül Pulular
  • Dudu Solakoğlu Kahraman
  • Umut Varol
  • Sevil Sayhan
  • Duygu Ayaz
  • Cem Karaali
Eur J Breast Health 2022; 18: 336-342 DOI: 10.4274/ejbh.galenos.2022.2022-5-1 PMID:36248749
Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes
  • Selman Emiroglu
  • Mustafa Tukenmez
  • Seyma Karakus
  • Hasan Karanlik
  • Semen Onder
  • Vahit Ozmen
  • Neslihan Cabioglu
  • Enver Ozkurt
  • Ravza Yilmaz
  • Mahmut Muslumanoglu
Eur J Breast Health 2022; 18: 353-359 DOI: 10.4274/ejbh.galenos.2022.2022-8-1 PMID:36248750

Original Articles

IS TUMOR VOLUME MEASUREMENT MORE BENEFICIAL THAN TUMOR DIAMETER IN BREAST CANCER STAGING?
  • Nilüfer Yazgan Yıldırım
  • Ahmet Serkan İlgün
  • Ebru Şen Oran
  • Yücel Yankol
  • Sibel Gürdal Özkan
  • Doğan Gönüllü
  • Gürsel Remzi Soybir
  • Ferda Nihat Köksoy
Eur J Breast Health 2012; 8: 130-133
PROFILES AND PREDICTIVE FACTORS IN YOUNG AGE BREAST CANCER PATIENTS (RETROSPECTIVE STUDY)
  • Erol Aksaz
  • Güven Atasoy
  • Tayanç Öncel
  • Turay Yazıcı
  • Adil Aydemir
  • Nuray İpek
  • Dilek Bitik
Eur J Breast Health 2012; 8: 175-179

Review

Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer
  • E. Nilüfer Güler
Eur J Breast Health 2017; 13: 168-174 DOI: 10.5152/ejbh.2017.3636